Cellular and Molecular Signaling as Targets for Cancer Vaccine Therapeutics

Plenty of evidence has recently shown that various inflammatory activities at the local tissue, organ, or even the whole body (systemic) level are strongly linked to many life-threatening chronic diseases, most notably various cancers. However, only very limited information is available for making g...

Full description

Bibliographic Details
Main Authors: Wen-Chi Wei, Lie-Fen Shyur, Ning-Sun Yang
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/11/9/1590
_version_ 1797505288260026368
author Wen-Chi Wei
Lie-Fen Shyur
Ning-Sun Yang
author_facet Wen-Chi Wei
Lie-Fen Shyur
Ning-Sun Yang
author_sort Wen-Chi Wei
collection DOAJ
description Plenty of evidence has recently shown that various inflammatory activities at the local tissue, organ, or even the whole body (systemic) level are strongly linked to many life-threatening chronic diseases, most notably various cancers. However, only very limited information is available for making good use of our supporting immune-modulatory therapeutics for the treatment of cancers. This may result from a lack of studies on specific remedies for efficacious control or modulatory suppression of inflammation-related cancerous diseases. Our group and laboratories were fortunate to have initiated and consistently pursued an integrated team-work program project, aimed at investigating selected medicinal herbs and the derived, purified phytochemical compounds. We focused on the study of key and specific immune-signaling mechanisms at the cellular and molecular levels. We were fortunate to obtain a series of fruitful research results. We believe that our key findings reported herein may be helpful for proposing future thematic and integrated research projects that aim to develop future phytochemical drugs against cancers. The mechanisms of the cellular and molecular systems involved in inflammation are becoming increasingly recognized as keystones for the development of future therapeutic approaches for many chronic and cancerous diseases. Recently, the immune checkpoint inhibitors such as antibodies against PD-1 and/or PD-L1 have been shown to be too expensive for general clinical use, and their effects far from optimal, often showing little or no effect or only short-term efficacy. These results point to the need for developing future immune-regulatory or modulatory therapeutics.
first_indexed 2024-03-10T04:16:28Z
format Article
id doaj.art-e0971d20542e4578a3a71a38e50da290
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T04:16:28Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-e0971d20542e4578a3a71a38e50da2902023-11-23T08:01:29ZengMDPI AGCells2073-44092022-05-01119159010.3390/cells11091590Cellular and Molecular Signaling as Targets for Cancer Vaccine TherapeuticsWen-Chi Wei0Lie-Fen Shyur1Ning-Sun Yang2National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei 112, TaiwanAgricultural Biotechnology Research Center, Academia Sinica, Taipei 115, TaiwanAgricultural Biotechnology Research Center, Academia Sinica, Taipei 115, TaiwanPlenty of evidence has recently shown that various inflammatory activities at the local tissue, organ, or even the whole body (systemic) level are strongly linked to many life-threatening chronic diseases, most notably various cancers. However, only very limited information is available for making good use of our supporting immune-modulatory therapeutics for the treatment of cancers. This may result from a lack of studies on specific remedies for efficacious control or modulatory suppression of inflammation-related cancerous diseases. Our group and laboratories were fortunate to have initiated and consistently pursued an integrated team-work program project, aimed at investigating selected medicinal herbs and the derived, purified phytochemical compounds. We focused on the study of key and specific immune-signaling mechanisms at the cellular and molecular levels. We were fortunate to obtain a series of fruitful research results. We believe that our key findings reported herein may be helpful for proposing future thematic and integrated research projects that aim to develop future phytochemical drugs against cancers. The mechanisms of the cellular and molecular systems involved in inflammation are becoming increasingly recognized as keystones for the development of future therapeutic approaches for many chronic and cancerous diseases. Recently, the immune checkpoint inhibitors such as antibodies against PD-1 and/or PD-L1 have been shown to be too expensive for general clinical use, and their effects far from optimal, often showing little or no effect or only short-term efficacy. These results point to the need for developing future immune-regulatory or modulatory therapeutics.https://www.mdpi.com/2073-4409/11/9/1590cancer immunotherapyDC-based cancer vaccineimmunogenic cell death (ICD)tumor microenvironmentphytochemicals
spellingShingle Wen-Chi Wei
Lie-Fen Shyur
Ning-Sun Yang
Cellular and Molecular Signaling as Targets for Cancer Vaccine Therapeutics
Cells
cancer immunotherapy
DC-based cancer vaccine
immunogenic cell death (ICD)
tumor microenvironment
phytochemicals
title Cellular and Molecular Signaling as Targets for Cancer Vaccine Therapeutics
title_full Cellular and Molecular Signaling as Targets for Cancer Vaccine Therapeutics
title_fullStr Cellular and Molecular Signaling as Targets for Cancer Vaccine Therapeutics
title_full_unstemmed Cellular and Molecular Signaling as Targets for Cancer Vaccine Therapeutics
title_short Cellular and Molecular Signaling as Targets for Cancer Vaccine Therapeutics
title_sort cellular and molecular signaling as targets for cancer vaccine therapeutics
topic cancer immunotherapy
DC-based cancer vaccine
immunogenic cell death (ICD)
tumor microenvironment
phytochemicals
url https://www.mdpi.com/2073-4409/11/9/1590
work_keys_str_mv AT wenchiwei cellularandmolecularsignalingastargetsforcancervaccinetherapeutics
AT liefenshyur cellularandmolecularsignalingastargetsforcancervaccinetherapeutics
AT ningsunyang cellularandmolecularsignalingastargetsforcancervaccinetherapeutics